|
[1]
|
Vaginal progesterone for the prevention of preterm birth: who can benefit and who cannot? Evidence-based recommendations for clinical use
Journal of Perinatal Medicine,
2023
DOI:10.1515/jpm-2022-0462
|
|
|
|
|
[2]
|
Vaginal progesterone for the prevention of preterm birth: who can benefit and who cannot? Evidence-based recommendations for clinical use
Journal of Perinatal Medicine,
2023
DOI:10.1515/jpm-2022-0462
|
|
|
|
|
[3]
|
Does vaginal progesterone prevent recurrent preterm birth in women with a singleton gestation and a history of spontaneous preterm birth? Evidence from a systematic review and meta-analysis
American Journal of Obstetrics and Gynecology,
2022
DOI:10.1016/j.ajog.2022.04.023
|
|
|
|
|
[4]
|
Vaginal progesterone does not prevent recurrent preterm birth in women with a singleton gestation, a history of spontaneous preterm birth, and a midtrimester cervical length >25 mm
American Journal of Obstetrics and Gynecology,
2022
DOI:10.1016/j.ajog.2022.07.054
|
|
|
|
|
[5]
|
Vaginal progesterone does not prevent recurrent preterm birth in women with a singleton gestation, a history of spontaneous preterm birth, and a midtrimester cervical length >25 mm
American Journal of Obstetrics and Gynecology,
2022
DOI:10.1016/j.ajog.2022.07.054
|
|
|
|
|
[6]
|
Does vaginal progesterone prevent recurrent preterm birth in women with a singleton gestation and a history of spontaneous preterm birth? Evidence from a systematic review and meta-analysis
American Journal of Obstetrics and Gynecology,
2022
DOI:10.1016/j.ajog.2022.04.023
|
|
|
|
|
[7]
|
Vaginal progesterone does not prevent recurrent preterm birth in women with a singleton gestation, a history of spontaneous preterm birth, and a midtrimester cervical length >25 mm
American Journal of Obstetrics and Gynecology,
2022
DOI:10.1016/j.ajog.2022.07.054
|
|
|
|